5. Krinsley JS. Glycemic variability: a strong independent predictor of mortality in critically ill patients. Crit Care Med 2008;36:3008-13.
10. Monnier L, Mas E, Ginet C, Michel F, Villon L, Cristol JP, et al. Activation of oxidative stress by acute glucose fluctuations compared with sustained chronic hyperglycemia in patients with type 2 diabetes. JAMA 2006;295:1681-7.
11. Risso A, Mercuri F, Quagliaro L, Damante G, Ceriello A. Intermittent high glucose enhances apoptosis in human umbilical vein endothelial cells in culture. Am J Physiol Endocrinol Metab 2001;281:E924-30.
12. Quagliaro L, Piconi L, Assaloni R, Martinelli L, Motz E, Ceriello A. Intermittent high glucose enhances apoptosis related to oxidative stress in human umbilical vein endothelial cells: the role of protein kinase C and NAD(P)H-oxidase activation. Diabetes 2003;52:2795-804.
14. Hu GC, Hsieh SF, Chen YM, Hsu HH, Hu YN, Chien KL. Relationship of initial glucose level and all-cause death in patients with ischaemic stroke: the roles of diabetes mellitus and glycated hemoglobin level. Eur J Neurol 2012;19:884-91.
15. Quagliaro L, Piconi L, Assaloni R, Da Ros R, Maier A, Zuodar G, et al. Intermittent high glucose enhances ICAM-1, VACM-1 and E-selectin expression in human umbilical vein endothelial cells in culture: The distinct role of protein kinase C and mitochondrial superoxide production. Atherosclerosis 2005;183:259-67.
16. Esposito K, Nappo F, Marfella R, Giugliano G, Giugliano F, Ciotola M, et al. Inflammatory cytokine concentrations are acutely increased by hyperglycemia in humans: role of oxidative stress. Circulation 2002;106:2067-72.
17. Park JM, Cho YJ, Lee KB, Park TH, Lee SJ, Han MK, et al. Internet-based control recruitment for a case-control study of major risk factors for stroke in Korea: lessons from the experience. J Stroke Cerebrovasc Dis 2014;23:2559-65.
18. Lambert M. ADA releases revisions to recommendations for standards of medical care in diabetes. Am Fam Physician 2012;85:514-5.
20. Wojcicki JM. “J”-index. A new proposition of the assessment of current glucose control in diabetic patients. Horm Metab Res 1995;27:41-2.
21. Li Z, Sun L, Zhang H, Liao Y, Wang D, Zhao B, et al. Elevated plasma homocysteine was associated with hemorrhagic and ischemic stroke, but methylenetetrahydrofolate reductase gene C677T polymorphism was a risk factor for thrombotic stroke: a multicenter case-control study in China. Stroke 2003;34:2085-90.
22. Meyer BC, Hemmen TM, Jackson CM, Lyden PD. Modified national institutes of health stroke scale for use in stroke clinical trials: prospective reliability and validity. Stroke 2002;33:1261-6.
23. Desilles JP, Meseguer E, Labreuche J, Lapergue B, Sirimarco G, Gonzalez-Valcarcel J, et al. Diabetes mellitus, admission glucose, and outcomes after stroke thrombolysis: a registry and systematic review. Stroke 2013;44:1915-23.
24. Tiruvoipati R, Chiezey B, Lewis D, Ong K, Villanueva E, Haji K, et al. Stress hyperglycemia may not be harmful in critically ill patients with sepsis. J Crit Care 2012;27:153-8.
25. Baird TA, Parsons MW, Phan T, Butcher KS, Desmond PM, Tress BM, et al. Persistent poststroke hyperglycemia is independently associated with infarct expansion and worse clinical outcome. Stroke 2003;34:2208-14.
26. Carandang R, Seshadri S, Beiser A, Kelly-Hayes M, Kase CS, Kannel WB, et al. Trends in incidence, lifetime risk, severity, and 30-day mortality of stroke over the past 50 years. JAMA 2006;296:2939-46.
27. Rothwell PM, Coull AJ, Giles MF, Howard SC, Silver LE, Bull LM, et al. Change in stroke incidence, mortality, case-fatality, severity, and risk factors in oxfordshire, UK from 1981 to 2004 (Oxford Vascular study). Lancet 2004;363:1925-33.
28. Nakayama H, Jørgensen HS, Raaschou HO, Olsen TS. The influence of age on stroke outcome. The copenhagen stroke study. Stroke 1994;25:808-13.
29. Petty GW, Brown RD Jr, Whisnant JP, Sicks JD, O’Fallon WM, Wiebers DO. Survival and recurrence after first cerebral infarction: a population-based study in Rochester, Minnesota, 1975 through 1989. Neurology 1998;50:208-16.
30. Dhamoon MS, Sciacca RR, Rundek T, Sacco RL, Elkind MS. Recurrent stroke and cardiac risks after first ischemic stroke: the Northern Manhattan study. Neurology 2006;66:641-6.
31. Jang IM, Lee KB, Roh H, Ahn MY. Influence of chronic kidney disease on mortality after acute ischemic stroke. J Korean Neurol Assoc 2009;27:229-36.
32. Klein R. Hyperglycemia and microvascular and macrovascular disease in diabetes. Diabetes Care 1995;18:258-68.
33. Haidara MA, Yassin HZ, Rateb M, Ammar H, Zorkani MA. Role of oxidative stress in development of cardiovascular complications in diabetes mellitus. Curr Vasc Pharmacol 2006;4:215-27.
34. Baynes JW. Role of oxidative stress in development of complications in diabetes. Diabetes 1991;40:405-12.
36. Vlassara H. Recent progress in advanced glycation end products and diabetic complications. Diabetes 1997;46 Suppl 2:S19-25.
37. O’Brien R, Timmins K. The role of oxidation and glycation in the pathogenesis of diabetic atherosclerosis. Trends Endocrinol Metab 1994;5:329-34.
38. Lyons TJ. Glycation and oxidation: a role in the pathogenesis of atherosclerosis. Am J Cardiol 1993;71:26B-31B.
39. Giugliano D, Ceriello A, Paolisso G. Diabetes mellitus, hypertension, and cardiovascular disease: which role for oxidative stress? Metabolism 1995;44:363-8.
40. Park L, Raman KG, Lee KJ, Lu Y, Ferran LJ Jr, Chow WS, et al. Suppression of accelerated diabetic atherosclerosis by the soluble receptor for advanced glycation endproducts. Nat Med 1998;4:1025-31.
41. Watada H, Azuma K, Kawamori R. Glucose fluctuation on the progression of diabetic macroangiopathy--new findings from monocyte adhesion to endothelial cells. Diabetes Res Clin Pract 2007;77 Suppl 1:S58-61.
42. Bae HJ, Yoon DS, Lee J, Kim BK, Koo JS, Kwon O, et al. Inhospital medical complications and long-term mortality after ischemic stroke. Stroke 2005;36:2441-5.